Quality medicines for all
Ensuring that patients in the developing world get access to the medicines they need remains an unfulfilled desire. This is true in spite of the significant progress over the last decade in providing treatment to poor people suffering in particular from the "big three" pandemics, HIV/AIDS, malaria and tuberculosis. The reasons for this access gap are manifold, which points at a need for multiple responses by a diverse set of actors: policymakers, businesses, civil society at large, as well as development partners at national and international levels alike.
Related Content
- Africa regional strategy on antimicrobial resistance communications and advocacy
- Review of Policies and Strategies for the Pharmaceutical Production Sector in Africa
- Short-term elevation of fine particulate matter air pollution and acute lower respiratory infection
- Comparative analysis of grain quality and nutraceutical properties of selected rice varieties from Kerala
- Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship
- Draft Pharmaceutical Policy, 2017